Moberg Pharma AB Company Description

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden.

It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013.

Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

Moberg Pharma AB (publ)

Country	Sweden
Founded	2006
Industry	Pharmaceutical Preparations
Employees	10
CEO	Anna Ljung

Contact Details

Address: Gustavslundsvägen 42 Bromma, 167 51 Sweden
Phone	46 8 52 23 07 00
Website	mobergpharma.se

Stock Details

Ticker Symbol	MBGPF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	SEK
SIC Code	2834

Key Executives

Name	Position
Anna Ljung	Chief Executive Officer
Mark Beveridge	Chief Financial Officer
Christina Erixon	Chief Operating Officer